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Disruptionoftightjunctionsisoftenseenduringpathogeninfection,inﬂammation,andtumorprogression.Mislocalizationofthe
tightjunctionproteinsoccludinandclaudininmammaryepithelialmonolayersleadstoapoptosisthroughtheextrinsicpathway.
Tofurtherinvestigatethemechanismofthisresponse,anormalmammaryepithelialcellline(EpH4)aswellasprimarymammary
epithelial cells were treated with a claudin-disrupting mimic peptide, DFYNP(aspartic acid–phenylalanine–tyrosine–asparagine–
proline).Usingﬂuorescentindicators,wefoundthatcaspase-3activation,resultingfromtreatmentwithDFYNP,wasrestrictedto
EpH4 and primary mammary epithelial cells with mislocalized claudin-4. Mislocalized claudin-4 and occludin were colocalized in
non-junctional puncta, and both molecules were found in the death-inducing signaling complex (DISC) where they colocalized
with Fas, fas-associated protein with death domain (FADD), active caspase-8 and caspase-3 at distinct apical domains.
Importantly, caspase-3 activation was totally repressed in primary mammary epithelial cells from occludin null mice. Thus, the
apoptotic response appears to be initiated by the movement of occludin to the DISC suggesting that this molecule has signaling
properties that initiate cell death when its tight junction location is disrupted.
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Tight junction disruption has an important role in several
pathologies including viral and bacterial infection,
1,2 inﬂam-
mation,
3,4 and tumor progression.
5 Claudin and occludin are
major transmembrane proteins of the tight junction that
provide tight control over paracellular diffusion within an
epithelium. Interestingly, claudin and occludin are often
targeted and misplaced by viruses,
1,6 bacteria,
7,8 and
inﬂammatory cytokines.
8,9 Although apoptosis is observed in
many diseases that involve disrupted tight junctions,
10–12 the
role displaced tight junction proteins may have in the initiation
of apoptosis has not been investigated. Importantly, it is not
known whether changes in localization of key tight junction
proteins, such as claudin and occludin, may be initiating
important signaling pathways to preserve the barrier proper-
ties of a compromised epithelial monolayer.
Previously, we have shown, using a mimic peptide to a
conserved sequence in the second extracellular loop of
occludin, that disruption of normal occludin–occludin interac-
tions at the tight junction leads to mislocalization of occludin
away from tight junctions and into the cytosol.
13 This
mislocalized occludin interacted with components of the
death-inducing signaling complex (DISC), such as fas-
associated protein with death domain (FADD) and cleaved
caspase-8, and induced activation of the extrinsic apoptotic
pathway. This ﬁnding suggested that occludin not only has a
role in barrier formation, but may also be a signaling molecule
that induces apoptosis when normal tight junction protein
interactions are disrupted. When normal claudin–claudin
interactions were disrupted, using similar peptide mimic
technology, claudin also mislocalized away from tight junc-
tions into the cytosol.
14 The mislocalization of claudin led to
the activation of caspase-8 and -3, similar to what was seen
whenoccludinwasdisrupted,andsuggestedthatclaudinmay
also be having an important role in cell fate signaling in
response to tight junction disruption.
In the present study, the signaling mechanism involved in
apoptosis induced by claudin and occludin disruption was
further investigated. We asked whether both proteins work
through the same pathway or whether one protein is a
universal trigger for apoptosis when tight junctions are
disrupted. Normal mammary epithelial cells were treated with
a claudin mimic peptide, DFYNP (aspartic acid–phenylala-
nine–tyrosine–asparagine–proline), and changes in localiza-
tion of claudin and occludin were examined in relation to each
other as well as to key apoptotic signaling molecules. The
results show that both claudin and occludin move from tight
junctions to distinct apical domains where they colocalize with
components of the DISC to induce apoptosis. However, it is
occludin that is required for induction of apoptosis.
Results
Apoptosis is restricted to epithelial cells with
mislocalized claudin. To conﬁrm that disruption of normal
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www.nature.com/cddisclaudin localization leads to apoptosis, cells were examined
for localization of both claudin-4 and active caspase-3 in the
absence and presence of the claudin-disrupting DFYNP
mimic peptide. Immunohistochemistry, using antibodies
directed to claudin-4 (a claudin subtype that contains
DFYNP in the second extracellular loop) and cleaved
caspase-3, revealed that claudin-4 is largely restricted to
tight junctions and caspase-3 was not activated in untreated
EpH4 mammary epithelial cells (Figure 1). After 16h of
treatment with the claudin mimic peptide, claudin-4
localization changed dramatically, with a signiﬁcant
proportion of claudin in the cytosol. Treated cells also
showed activated caspase-3.
Occludin is disrupted when claudin is mislocalized. As
occludin mislocalization can also lead to apoptosis,
13 we
wanted to test whether or not occludin is disrupted in
response to claudin mislocalization. Claudin-4 and occludin
localization were examined simultaneously in the absence
and presence of the claudin mimic peptide. In untreated
EpH4 cells, both claudin-4 and occludin are restricted to tight
junctions (Figure 2). After 16h of treatment with the claudin
mimic peptide, disruption of claudin-4 was very clear in
deﬁned groups of treated cells where claudin-4 appeared to
be less regularly distributed in the tight junctions than in
controls. Occludin was also mislocalized into non-junctional
puncta in treated EpH4 cells, but there was still a strong
presence of occludin at the tight junction. Interestingly, bright
puncta of non-junctional occludin colocalized with non-
junctional puncta of claudin-4. This observation suggests
occludin is also mislocalized in response to claudin disruption
and interacts with claudin in distinct vesicular-like domains.
Claudin and occludin colocalize with components of the
DISC. The extrinsic apoptotic pathway is characterized by
the activation of a death receptor and formation of the DISC,
of which FADD and cleaved caspase-8 are key components,
and initiation of the caspase cascade. EpH4 cells treated with
DAPI cleaved casp-3 claudin-4 overlay
(-) claudin peptide
(+) claudin peptide
Figure 1 Caspase-3 is activated in cells with mislocalized claudin. Confocal microscopy images show staining of EpH4 mammary epithelial monolayers for active
caspase-3 (red), claudin-4 (green), and nuclei (blue). Caspase-3 is activated in cells treated with the DFYNP claudin mimic peptide where activation is restricted to cells with
non-junctional claudin-4 localization
claudin-4 occludin overlay
(-) claudin peptide 
(+) claudin peptide
Figure 2 Colocalization of occludin and claudin. Confocal microscopy images show staining of EpH4 mammary epithelial monolayers for claudin-4 (green) and occludin
(red) in the absenceand presenceof the claudinmimic peptide. Claudin-4 and occludin both localizeto sites of tightjunctions in untreated epithelium. After treatment with the
claudin mimic peptide, bright puncta of non-junctional occludin colocalize with bright puncta of non-junctional claudin-4
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Cell Death and Diseasethe claudin mimic peptide for 4h showed non-junctional
occludin colocalized with aggregated FADD and cleaved
caspase-8 (Figures 3a and c). Immunohistochemistry also
showed colocalization of claudin-4 with aggregated FADD
and active caspase-8 (Figures 3b and d). These data
suggest that both occludin and claudin interact with the
DISC in response to claudin disruption with the DFYNP
mimic peptide. Figure 3e conﬁrms localization of both
occludin and claudin at sites of DISC formation, with
occludin and claudin-4 colocalizing with active caspase-8.
Interestingly, z-stack images of claudin and occludin with the
DISC reveal restriction of claudin, occludin, FADD, and
caspase-8 to an apical, vesicle-like domain within the
cytoplasm near a tricellular junction (Figures 3c–e). The
aggregation and activation of death receptors is thought to be
upstream of FADD and caspase-8 recruitment into the DISC.
Immunohistochemistry reveals that the Fas receptor is
aggregated and also colocalized within the DISC formed in
response to claudin disruption with the mimic peptide
(Figure 4a). Downstream of procaspase-8 recruitment to
Claudin-4
FADD
Caspase-8
Occludin
FADD
Caspase-8
Occludin
Claudin-4
Caspase-8
caspase-8 occludin
FADD
caspase-8 claudin-4
FADD
Figure 3 Colocalization of occludin, claudin-4, and components of the death inducing signaling complex (DISC). Magniﬁed ( 100) confocal microscopy images show
staining of EpH4 mammary epithelial monolayers for: (a) occludin (red), active caspase-8 (white), and FADD (green); (b) claudin-4 (red), active caspase-8 (white), and FADD
(green)aftertreatmentofcellswiththeclaudinmimicpeptidefor4h.Claudin-4andoccludinbothcolocalizewithactivecaspase-8andFADDinresponsetotreatmentwiththe
peptide. Z-stack images show: (c) EpH4 cells stained for nuclei (DAPI, blue), occludin (red), FADD (white), and active caspase-8 (green); (d) cells stained for nuclei (blue),
claudin-4 (red), FADD (white), and active caspase-8 (green); or (e) cells stained for nuclei (blue), occludin (red), claudin-4 (white), and active caspase-8 (green). Occludin,
claudin-4, FADD, and active caspase-8 colocalize to distinct apical domains in response to treatment with the claudin mimic peptide
caspase-8 Claudin-4
Caspase-3
caspase-8 Claudin-4
FAS
Figure 4 Fas and caspase-3 colocalize with claudin and DISC components. Magniﬁed ( 100) confocal microscopy images show staining of EpH4 mammary epithelial
monolayersforactivecaspase-8(green),claudin-4(white)and(a)Fasor(b)activecaspase-3(red)after4hoftreatmentwiththeclaudinmimicpeptide.Claudin-4colocalizes
with active caspase-8 as well as Fas and activated caspase-3 in response to peptide treatment
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Cell Death and Diseasethe DISC, and subsequent activation of caspase-8, is the
activation of effector caspases, such as caspase-3, that carry
out the enzymatic cleavage of other cellular proteins. Active
caspase-3 was also found within the DISC in response to
claudin disruption with the mimic peptide (Figure 4b).
Therefore, in response to claudin disruption, claudin and
occludin move out of the tight junction and interact with the
key protein components of the intrinsic apoptotic signaling
pathway.
Occludin disruption is downstream of claudin
mislocalization. The presence of occludin at the DISC
when claudin localization is disrupted and caspase activation
is induced further suggests that occludin may be having a
key role in activation of apoptosis in response to tight junction
disruption. To determine whether claudin and occludin act
together to induce apoptosis when tight junctions are
disrupted or whether occludin is the downstream sensor of
tight junction disruption and trigger of apoptosis, we
examined the localization of claudin during occludin
disruption. Using immunohistochemistry, localization of
claudin-4 was imaged after treatment with an occludin-
disrupting mimic peptide LYHY (lysine–tyrosine–histidine–
tyrosine).
13 Figure 5 shows that claudin-4 remained at the
sites of tight junctions after treatment of the cells with the
occludin-disrupting peptide. These data suggest that
occludin, in fact, is acting downstream of claudin disruption
to activate apoptosis and that occludin is more of a universal
‘trigger’ of apoptosis when tight junctions are disrupted.
Occludin is required for apoptosis induced by claudin
disruption. To further test this hypothesis that occludin is
the trigger of apoptosis when tight junctions are disrupted, we
examined the ability of the claudin mimic peptide to induce
apoptosis in the absence of occludin. Primary mammary
epithelial cells were isolated from pregnancy day-15 occludin
null-transgenic mice and compared with primary mammary
epithelial cells isolated from wild-type mice of the same
background (FVB). Western blot analysis (Figure 6a)
conﬁrmed that the occludin protein was absent in tissue
from the occludin null mouse. Next, we examined claudin-4
localization in the occludin knockout mammary epithelial cells
to determine whether claudin-4 localizes to the tight junctions
in the absence of occludin. Results show that claudin-4 is,
indeed, localized to the tight junctions in the occludin
knockout mammary epithelium (Figure 6b). After treatment
with the claudin mimic peptide, claudin-4 localization was
signiﬁcantly disrupted (Figure 6c), similar to what we saw
with the EpH4 cell line. Next, the ability of the peptide to
induce apoptosis in the absence of occludin was examined.
Wild-type mammary epithelial cells treated with the claudin
mimic peptide showed a signiﬁcant increase in activated
caspase-3 (8.09±0.48% of cells, P¼0.0000169 versus
control) versus untreated wild-type control cells
(1.39±0.21% of cells, Figure 7). Claudin disruption did not
induce apoptosis in occludin null mammary epithelial cells,
showing a similar level of caspase-3 activation (1.59±0.16%
of cells, P¼0.82013 versus control) as untreated wild-type
control cells. Interestingly, although claudin-4 was
mislocalized, the change in its localization was unable to
elicit the apoptotic response. This observation provides
strong evidence that occludin mediates the apoptotic
response induced by disruption of tight junction proteins.
Discussion
Tightjunctiondisruptionisusuallythoughtofasadownstream
consequence of caspase cleavage during the apoptotic
process. Results from the present study, however, suggest
thattightjunctiondisruptioncanbeanearlyeventthatinitiates
caspase activation and cell death. Previously, we have shown
that disruption of the normal tight junctional localization of
occludin
13 and claudin
14 with mimic peptides can induce
apoptosis in normal epithelium. Immunoprecipitation along
withimmunohistochemistryconﬁrmedthatoccludinphysically
interacts with the DISC via the adaptor molecule FADD.
13 In
the present study, we have demonstrated that both occludin
andclaudincaninteractwithcomponentsoftheDISC,butthat
occludinisrequiredfortheinductionofapoptosis.Therefore,it
appears that occludin is having an important role in sensing
tight junction disruption and initiating apoptosis, a highly regu-
lated form of cell death. As apoptotic cells can be extruded
(+) occludin peptide (-) occludin peptide
claudin-4
Figure 5 Claudin is not disrupted when occludin is disrupted. Confocal microscopy images show staining of EpH4 mammary epithelial monolayers for claudin-4 in the (a)
absence and (b) presence of an occludin-disrupting LYHY mimic peptide. Claudin-4 remains at sites of tight junctions when occludin is disrupted
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Cell Death and Diseasefrom the epithelial monolayer with no change in epithelial
resistance, a regulated cell death response to compromised
cell junctions would provide a protective mechanism for
maintaining barrier properties within an epithelium.
The implication that occludin may have a role outside of
tight junction barrier formation can be inferred from the ﬁrst
experiments with occludin knockout mice: normally function-
ing tight junctions can form in the absence of occludin.
15 The
hypothesis that occludin has an important role in cell death
signaling is supported by the results of the current study that
show apoptosis is inhibited when occludin is absent. A
hallmark characteristic of tumor cells is that they are resistant
to apoptosis. That occludin can have a key role in apoptosis is
supported by the reported loss of occludin expression in
endometrial
16 and breast
17 carcinomas. Interestingly, Osanai
et al.
18 have shown that forced expression of occludin in a
cervical cancer cell line (HeLa) that does not express occludin
increased sensitivity of these cells to oxidative stress-induced
apoptosis, further implicating occludin in apoptotic signaling.
The mechanism by which tight junction disruption leads to
the interaction of occludin and claudin with the extrinsic
apoptotic signaling pathway is not fully understood. Pre-
viously, we have shown that occludin can bind to FADD when
tight junctions are disrupted.
13 It is possible that displaced
occludin is able to interact with FADD by movement within or
between plasma membrane domains. Tight junction proteins,
including occludin, have been found in cholesterol-rich lipid
raft-like microdomains in the plasma membrane.
19,20 The Fas
deathreceptorhasalso beenfoundinlipidraftdomains,being
recruited to lipid rafts upon stimulation, and further recruiting
FADD and procaspase-8 for assembly of the death inducing
signaling complex.
21,22 Whether or not occludin is having a
role in recruiting FADD downstream of Fas stimulation is
unknown. However, Algeciras-Schimnich et al.
21 have shown
that FADD and procaspase-8 recruitment to the DISC and
activation of caspase-8 is required for clustering of FAS at the
plasma membrane and internalization of the DISC. Therefore,
it is possible the occludin interaction with FADD may be the
initiating factor for DISC assembly, followed by clustering of
Fas and internalization of the entire complex. It is also
possible that the complex is responsible for the distinct
vesicle-like apical domains seen in the z-stack images in
Figure 3.
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Figure 7 Occludin is required for peptide-induced caspase-3 activation.
Cultured monolayers of primary mammary epithelial cells from wild-type and
occludin null-transgenic mice were treated with the claudin mimic peptide. After
16h,thenumberofcaspase-3-positivecellswasmeasured.Caspase-3activationin
response to the claudin mimic peptide was inhibited in cells that lacked occludin
protein expression. Mean±S.E.M., n¼3–6, *Po0.05 versus untreated
(-) claudin peptide (+) claudin peptide
claudin-4
occludin
occludin (+/+)
occludin (-/-)
Figure 6 Claudin localization is disrupted in occludin null cells. (a) Western blot analysis of occludin protein expression was performed with tissue lysates from wild-type
(þ/þ) and occludin null ( / ) mice to conﬁrm the loss of occludin protein in occludin null cells. Confocal images show cultured monolayers of primary mammary epithelial
cellsisolated fromoccludin nullmice stainedfor claudin-4in the (b)absenceand (c) presenceof theclaudin mimicpeptidefor 16h before ﬁxation.In theabsenceof occludin,
claudin-4 is still able to change localization in response to the claudin mimic peptide
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Cell Death and DiseaseTight junction disruption, including occludin and claudin
mislocalization, has been observed in Crohn’s disease,
12,23
hepatitis C virus infection,
1,10 Helicobacter pylori infec-
tion,
8,11,24 and manyepithelial-derived tumors.
5Each ofthese
disorders is associated with either upregulation of apoptosis,
as seen in Crohn’s disease, hepatitis C virus, and H. pylori
infection,
12 or inhibition of apoptosis, as seen in breast
cancer.
17Itisapossibilitythatthesignaling pathwayidentiﬁed
in the current study may be contributing to the pathology of
these diseases, either being upregulated to create a leaky
epithelium or disrupted to create resistance to regulated cell
death. Understanding the interaction of tight junction proteins
with apoptotic signaling molecules will not only help to
elucidate the pathology of these diseases but may provide
potential therapeutic targets for their treatment.
Materials and Methods
Cell culture. EpH4 cells, a normal mouse mammary epithelial cell line, were
grown in Dulbecco’s modiﬁed Eagle’s medium (DMEM) supplemented with 5%
heat-inactivated fetal bovine serum (FBS), 1% penicillin/streptomycin, and 10mM
Hepes (Mediatech, Manassas, VA, USA). Growth media were refreshed every 3–5
days and cells were trypsinized (0.25% trypsin, EDTA, Mediatech) and plated 1:2
every 7 days. Cells were plated with a 1:1 surface area onto Lab-Tek glass 8-
chamber slides (NUNC, Rochester, NY, USA) for experiments.
Primary mammary epithelial cells were isolated from the mammary glands of
occludinwild-type(þ/þ)FVBmice(JacksonLaboratories, BarHarbor,ME,USA)
and occludin knockout ( / ) mice (kindly provided by Mikio Furuse, Kyoto
University, Japan
25) back-crossed onto FVB. The fourth and ﬁfth mammary glands
were dissected from pregnancy day-15 dams. Minced glands from the same mice
were placed in collagenase solution consisting of DMEM/F12 media (Mediatech),
2mg/ml collagenase A (Roche Applied Science, Indianapolis, IN, USA), and 50mg/
mlgentamycin(Mediatech).Tissue,incollagenasesolution,was incubatedat371C
withshakingat200r.p.m.for2h.Cellswerethenspunat1500r.p.m.for10minand
the pellet was pulse washed with phosphatebuffered saline(PBS, with calcium and
magnesium)5to10timesat1500r.p.m.for2s.Thepelletwasthenresuspendedin
growth media containing DMEM/F12 media, 1  ITS ( 10 stock, Sigma, St.
Louis, MO, USA), 100mg/ml epidermal growth factor (BD Biosciences, San Diego,
CA, USA), 5% FBS (Mediatech), 50mg/ml gentamycin (Mediatech), 1% penicillin/
streptomycin (Mediatech), and 2.5mg/ml FUNGIZONE (Gibco, Grand Island, NY,
USA), and plated on 8-well chamber slides coated with collagen (Sigma).
Immunoﬂuorescence. Cell monolayers were ﬁxed with 2% paraformal-
dehyde for 15min at room temperature after treatment with the D-form of a claudin
mimic peptide (D-DFYNP, synthesized by the Peptide and Protein Chemistry Core,
University of Colorado Denver, School of Medicine, Aurora, CO, USA
14)o ra n
occludin mimic peptide (LYHY, Peptide and Protein Chemistry Core
13). Cells were
thenpermeabilizedwith 0.5%TritonX-100 for 5min beforeblockingwith 2% bovine
serumalbuminfor1h.Cellsweretreatedwithmouseanti-claudin-4(1:200,Zymed,
Carlsbad, CA, USA), rabbit anti-claudin-4 (1:200, Zymed), rabbit anti-occludin
(1:100, Invitrogen, Camarillo, CA, USA), rabbit anti-cleaved caspase-3 (1:100,
Cell Signaling Technologies, Danvers, MA, USA), rat cleaved caspase-8 (1:100,
Enzo Life Sciences, San Diego, CA, USA), mouse anti-FADD (1:100, BD
Biosciences), mouse anti-Fas (1:100, Santa Cruz Biotechnology, Santa Cruz, CA,
USA) and/or rat anti-ZO-1 (1:50, Santa Cruz Biotechnology) primary antibodies for
1h. After washing with PBS, cells were treated with donkey anti-mouse-CY5,
donkey anti-mouse-FITC, donkey anti-rabbit-CY3, donkey anti-rat-FITC (1:150,
Jackson ImmunoResearch Laboratories, West Grove, PA, USA) for 45min.
Monolayers were then washed ﬁve times, 5min each, with PBS and OPDA
(20mg/ml o-phenylenediamine dihydrochloride in 1M Tris, pH 8.5) was applied
before addition of a coverslip. Fluorescence was imaged on an Olympus Spinning
Disk confocal microscope, using SlideBook software (Intelligent Imaging
Innovations, Inc., Denver, CO, USA).
Statistics. Data are presented as means±S.E.M. An unpaired Student’s
t-test was used for statistical comparison between control and treatment groups.
A P-value of o 0.05 was considered signiﬁcant.
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